New funding for Global Health Product Development Partnerships
FCDO has partnered with public-private Product Development Partnerships (PDPs) for more than 20 years to develop new medicines, vaccines and diagnostics for diseases and settings where commercial markets do not deliver. During 2024, FCDO conducted an international competitive call for proposals for Product development research for global health for funding during 2025–2028.
As announced by Minister for Development Baroness Chapman on 18 May 2026 (see press release), ten organisations have now been awarded funding and are supported by GRTD to develop new technologies for sexual and reproductive health, infectious diseases of poverty, and diseases with epidemic and pandemic potential.
FCDO supports end-to-end partnerships with clear equitable access plans built into their R&D, and with operations increasingly centred in the countries most affected. These new awards, which began between November 2024 and September 2025, will run until March 2028. They are:
• Medicines for Malaria Venture (MMV) – developing new drugs to prevent and treat malaria.
• TB Alliance (TBA) – developing new medicines and treatment regimens for tuberculosis.
• Drugs for Neglected Diseases initiative (DNDi) – developing life-saving treatments for neglected tropical diseases, including sleeping sickness and leishmaniasis.
• Innovative Vector Control Consortium (IVCC) – developing new vector control technologies, including mosquito nets.
• Programme for Appropriate Technology in Health (PATH) – expanding vaccine access, developing new syphilis diagnostics, and testing treatments for post-partum haemorrhage.
• Centre for Biomedical Research (CBR) at Population Council – developing next-generation contraceptive methods and vaginal ring technologies for contraceptive and antiretroviral use.
• International Vaccine Institute (IVI) – discovering and developing safe, effective and affordable vaccines, including for cholera.
• World Mosquito Program – advancing novel approaches to vector control.
• Liverpool School of Tropical Medicine’s ‘ENDPOINT’ programme– advancing new solutions for eliminable parasitic diseases spread by insects, including lymphatic filariasis.
• King’s College’s ‘Cradle Smart’ programme – developing low-cost, accessible point-of-care diagnostics for post-partum haemorrhage and pre-eclampsia in LMIC settings.
See more
Justice systems in low-resource and conflict-affected settings are often stretched to breaking point. In Malawi, for example, fewer than 800 lawyers serve a population of 22 million, and legal aid caseloads run into the tens of thousands
A major new international research and policy partnership is helping to shape the future of sustainable transport across low and middle-income countries.
Young Lives is a unique longitudinal research programme that has followed 12,000 young people in Ethiopia, India, Peru and Vietnam – from infancy to adulthood – for more than 2 decades.
Artificial intelligence is often presented as a new frontier for international development. But the Frontier Tech Hub’s 4-part newsletter series, On the Frontier of AI, tells a more grounded and useful story: AI is not new, not only about large language models, and not useful unless the right data, infrastructure, institutions and safeguards are in place.